Table 1. Patient characteristics.

Characteristics	Docetaxel Monotherapy	Docetaxel/Sunitinib
Patient Number	13	14
Treated per protocol	11 (85%)	11 (79%)
Median age (range)	67 (54–78)	69 (58–77)
Race
White	13 (100%)	13 (93%)
Asian	0 (0%)	1 (7%)
Disease Location
Bone	10 (77%)	12 (85%)
Node	1 (8%)	3 (21%)
Liver	1 (8%)	0 (0%)
Gleason score
≤7	4 (31%)	6 (43%)
8–10	7 (54%)	7 (50%)
Not available	2 (15%)	1 (7%)
Prostate-specific antigen
Median (range)	53.1 ng/dl (13.7–636.6)	30.35 ng/dl (12.5–3350)
Treatment primary tumor
Surgery	5 (38%)	7 (50%)
Radiation	3 (23%)	3 (21%)
Other	5 (38%)	4 (29%)
Prior hormone therapy
1 line	4 (31%)	6 (43%)
2 lines	7 (54%)	5 (36%)
3 lines	2 (15%)	3 (21%)